Record Demand, Real Tax Advantages, and the Window to Move

A MESSAGE FROM THE CEO

Dear Partners and Friends,

We’re now well into Q3, and one thing is clear: this market rewards clarity, not hesitation.

Despite headlines, uncertainty, and shifts in global capital flows, we’re seeing real opportunity where others see noise. In particular, the medical office space continues to shine, supported by long-term healthcare demand, stable tenancy, and a highly fragmented market that favors disciplined operators.

At Streamline Capital Group, we’re continuing to raise capital for SIG III, targeting value-add assets in growth markets like Phoenix. These aren’t speculative deals; they’re hard assets backed by real tenants and proven strategy.

We’re also seeing more of our investors take advantage of new tax advantages and SDIRA flexibility, putting capital to work in ways that deliver both cash flow and tax efficiency.

Let’s finish the quarter strong, together.

-David J. Hrizak, Chief Executive Officer, The Streamline Companies

---

MEDICAL OFFICE KEEPS MOVING FORWARD

A recent Bisnow article confirmed what we’re seeing on the ground: even with $1T in healthcare spending cuts proposed, medical office continues to hold firm, with investors and tenants alike showing confidence in its long-term viability.

Why?
✔ Demand is driven by demographics, not budget headlines
✔ Tenants like physicians, dentists, and outpatient clinics have high stickiness
✔ No remote work risk, and no flash-in-the-pan tech valuations

Medical office remains one of the most recession-resistant, operationally stable asset classes, and we’re positioned right at the heart of it.

---

🎙 FINANCIAL FREEDOM PODCAST

David recently joined Dr. Christopher H. Loo on the Financial Freedom Podcast to talk about building wealth beyond Wall Street. From 30 years of real estate experience to leading The Streamline Companies, David shares what it takes to create stable, tax-efficient income through medical and Class B office investing.

Inside this episode:
💼 Why the office sector isn’t dead, it’s just misunderstood
📈 How Streamline is capitalizing on recession-resistant demand
🧠 The power of discipline, vertical integration, and aligned partnerships
🏥 Why medical professionals are uniquely positioned to win in this asset class

Whether you’re a physician, entrepreneur, or legacy-focused investor, this episode is packed with insight for your next move.

---

SALES SLOW, BUT DEMAND SURGES — WHAT THAT REALLY MEANS FOR INVESTORS

A recent GlobeSt article highlights an interesting paradox: medical office sales are down, even though occupancy and tenant demand are hitting record highs.

That disconnect? It’s a direct result of cautious capital, not fundamentals.

And it creates a window of opportunity for firms like Streamline, who:
🔹 Have dry powder and a trusted investor base
🔹 Know how to unlock value in underpriced or under-managed assets
🔹 Are vertically integrated, controlling execution from day one

If you’ve been waiting to invest during a dip in pricing but with rising demand, this may be your moment.

📈 SIG III is open now.

---

INVESTOR TOOL SPOTLIGHT: DAVID’S AI ASSISTANT

Still have questions? Want answers now?

🤖 David’s AI Clone is your 24/7 investor assistant trained on real questions from investors like you.

You’ll get answers on:
✅ Depreciation and tax strategy
✅ Capital stacks and deal structures
✅ Streamline’s investment approach

Try it now. It’s fast, accurate, and available anytime you are.